ARMP vs DVN · $70.2M cap vs P/E 7.4, rev $7.42B
Armata Pharmaceuticals Inc (ARMP) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Armata Pharmaceuticals Inc (ARMP) is a biotechnology company listed on US.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
ARMP does not have a complete income-statement cache yet.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
ARMP currently screens at market cap $70.2M. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the ARMP and DVN stock pages for the full models.
Not investment advice.